U.S. Food and Drug Administration Office of the Commissioner
E886012
The U.S. Food and Drug Administration Office of the Commissioner is the central executive office that provides overall leadership, policy direction, and oversight for all FDA regulatory and public health activities.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Office of the Commissioner of Food and Drugs | 1 |
| U.S. Food and Drug Administration Office of the Commissioner canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T10790388 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: U.S. Food and Drug Administration Office of the Commissioner Context triple: [White Oak, Maryland, isNearFederalFacility, U.S. Food and Drug Administration Office of the Commissioner]
-
A.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
-
B.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
C.
FDA CFSAN
FDA CFSAN is the U.S. Food and Drug Administration’s center responsible for regulating the safety, labeling, and nutritional quality of foods, dietary supplements, and cosmetics.
-
D.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
E.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: U.S. Food and Drug Administration Office of the Commissioner Target entity description: The U.S. Food and Drug Administration Office of the Commissioner is the central executive office that provides overall leadership, policy direction, and oversight for all FDA regulatory and public health activities.
-
A.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
-
B.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
C.
FDA CFSAN
FDA CFSAN is the U.S. Food and Drug Administration’s center responsible for regulating the safety, labeling, and nutritional quality of foods, dietary supplements, and cosmetics.
-
D.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
E.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
- F. None of above. chosen
Statements (44)
| Predicate | Object |
|---|---|
| instanceOf |
executive office
ⓘ
office ⓘ organizational unit ⓘ |
| alternateName |
FDA Office of the Commissioner
NERFINISHED
ⓘ
Office of the Commissioner, FDA NERFINISHED ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| governsPolicyArea |
FDA-wide public health policy
ⓘ
FDA-wide regulatory policy ⓘ |
| hasComponent |
Office of External Affairs
NERFINISHED
ⓘ
Office of Minority Health and Health Equity NERFINISHED ⓘ Office of Policy NERFINISHED ⓘ Office of Regulatory Affairs (oversight and coordination role) NERFINISHED ⓘ Office of Women’s Health NERFINISHED ⓘ Office of the Chief Counsel NERFINISHED ⓘ Office of the Chief Scientist NERFINISHED ⓘ |
| hasFunction |
coordinates FDA response to major public health emergencies
ⓘ
issues agency-level guidance and policy statements ⓘ oversees FDA communications and public affairs ⓘ oversees FDA scientific integrity and research policy ⓘ provides legal and policy advice to FDA leadership ⓘ |
| hasHead | Commissioner of Food and Drugs NERFINISHED ⓘ |
| hasMandate |
advance public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable (through FDA as a whole)
ⓘ
protect public health by ensuring safety, efficacy, and security of FDA-regulated products (through FDA as a whole) ⓘ provide accurate, science-based information to the public about FDA-regulated products (through FDA as a whole) ⓘ |
| hasRole |
coordinates cross-cutting FDA initiatives
ⓘ
provides central management and direction for FDA programs ⓘ represents FDA leadership within the U.S. Department of Health and Human Services ⓘ represents FDA leadership within the U.S. federal government ⓘ sets agency-wide strategic priorities ⓘ |
| jurisdiction |
United States government
ⓘ
surface form:
federal government of the United States
|
| locatedIn | Silver Spring, Maryland (FDA headquarters) NERFINISHED ⓘ |
| oversees | FDA centers and offices ⓘ |
| parentOrganization | U.S. Department of Health and Human Services NERFINISHED ⓘ |
| partOf | U.S. Food and Drug Administration NERFINISHED ⓘ |
| regulatesThrough | FDA centers for drugs, biologics, devices, foods, and tobacco (oversight role) ⓘ |
| responsibleFor |
overall leadership of the U.S. Food and Drug Administration
ⓘ
oversight of FDA public health activities ⓘ oversight of FDA regulatory activities ⓘ policy direction for the U.S. Food and Drug Administration ⓘ |
| sector |
drug regulation
ⓘ
food safety regulation ⓘ medical product regulation ⓘ public health ⓘ |
| subordinateTo | Secretary of Health and Human Services NERFINISHED ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: U.S. Food and Drug Administration Office of the Commissioner Description of subject: The U.S. Food and Drug Administration Office of the Commissioner is the central executive office that provides overall leadership, policy direction, and oversight for all FDA regulatory and public health activities.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.